entertainment -WSS

entertainment

author：leisure time 2025-10-02 14:39:21 - browse：88951

Ford F-150 Recall — FILE - A 2021 F-150 pickup truck at a Ford dealer in southeast Denver, Oct. 24, 2021. Ford is recalling more than 870,000 newer F-150 pickup trucks in the U.S. because the electric parking brakes can turn on unexpectedly. The recall covers certain pickups from the 2021 through 2023 model years with single exhaust systems. Ford's F-Series pickups are the top-selling vehicles in the U.S. (AP Photo/David Zalubowski, File)The Associated Press

DEARBORN, Mich. -- Ford is recalling more than 870,000 newer F-150 pickup trucks in the U.S. because the electric parking brakes can turn on unexpectedly.

The recall covers certain pickups from the 2021 through 2023 model years with single exhaust systems. Ford's F-Series pickups are the top-selling vehicles in the U.S.

The company says in documents posted by government safety regulators Friday that a rear wiring bundle can come in contact with the rear axle housing. That can chafe the wiring and cause a short circuit, which can turn on the parking brake without action from the driver, increasing the risk of a crash.

Drivers may see a parking brake warning light and a warning message on the dashboard.

Ford says in documents that it has 918 warranty claims and three field reports of wire chafing in North America. Of these, 299 indicated unexpected parking brake activation, and 19 of these happened while the trucks were being driven.

The company says it doesn't know of any crashes or injuries caused by the problem.

Dealers will inspect the rear wiring harness. If protective tape is worn through, the harness will be replaced. If the tape isn't worn, dealers will install a protective tie strap and tape wrap.

Owners will be notified by letter starting Sept. 11.

Owners with questions can call Ford customer service at (866) 436-7332.

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Congress may force more Covid

WSS

WATCH: Why do our ears pop?

Measles policy set amid Florida outbreak alarms vaccine proponents

Orchard's therapy for neuron disease in children wins FDA approval

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Flagship Pioneering startup Sonata Therapeutics lays off 21

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

hotspot

entertainment

focus

After affirmative action ruling, medical educators look to 'holistic review'

MD Anderson's Padmanee Sharma responds to research credit suit

Wildfire smoke exposes gaps in outdoor worker protections

As AI regulations shape up, health tech startups beg for clarity

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Activists slam private health insurers over coverage restrictions

New CMS data security rules will hurt Medicare, Medicaid research

Drug repurposing or repositioning? The language matters

App could help diagnose ear infections more accurately — and at home

focus

Asbestos, a deadly carcinogen, banned by EPA

Opioid cravings were reduced by anti

Readout Newsletter: Bluebird, CVS, Contineum

AstraZeneca to buy developer of next

Baby aspirin cuts fat buildup in liver disease patients, in small study

Opioid cravings were reduced by anti

entertainment

explore

Wikipedia

focus